WNK2_HUMAN - dbPTM
WNK2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID WNK2_HUMAN
UniProt AC Q9Y3S1
Protein Name Serine/threonine-protein kinase WNK2 {ECO:0000305}
Gene Name WNK2 {ECO:0000312|HGNC:HGNC:14542}
Organism Homo sapiens (Human).
Sequence Length 2297
Subcellular Localization Cytoplasm . Cell membrane .
Protein Description Serine/threonine kinase which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation. Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively. Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5. Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression. Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1. WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity..
Protein Sequence MDGDGGRRDVPGTLMEPGRGAGPAGMAEPRAKAARPGPQRFLRRSVVESDQEEPPGLEAAEAPGPQPPQPLQRRVLLLCKTRRLIAERARGRPAAPAPAALVAQPGAPGAPADAGPEPVGTQEPGPDPIAAAVETAPAPDGGPREEAAATVRKEDEGAAEAKPEPGRTRRDEPEEEEDDEDDLKAVATSLDGRFLKFDIELGRGSFKTVYKGLDTETWVEVAWCELQDRKLTKLERQRFKEEAEMLKGLQHPNIVRFYDFWESSAKGKRCIVLVTELMTSGTLKTYLKRFKVMKPKVLRSWCRQILKGLLFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKSVIGTPEFMAPEMYEEHYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRKVTCGIKPASFEKVHDPEIKEIIGECICKNKEERYEIKDLLSHAFFAEDTGVRVELAEEDHGRKSTIALRLWVEDPKKLKGKPKDNGAIEFTFDLEKETPDEVAQEMIESGFFHESDVKIVAKSIRDRVALIQWRRERIWPALQPKEQQDVGSPDKARGPPVPLQVQVTYHAQAGQPGPPEPEEPEADQHLLPPTLPTSATSLASDSTFDSGQGSTVYSDSQSSQQSVMLGSLADAAPSPAQCVCSPPVSEGPVLPQSLPSLGAYQQPTAAPGLPVGSVPAPACPPSLQQHFPDPAMSFAPVLPPPSTPMPTGPGQPAPPGQQPPPLAQPTPLPQVLAPQPVVPLQPVPPHLPPYLAPASQVGAPAQLKPLQMPQAPLQPLAQVPPQMPPIPVVPPITPLAGIDGLPPALPDLPTATVPPVPPPQYFSPAVILPSLAAPLPPASPALPLQAVKLPHPPGAPLAMPCRTIVPNAPATIPLLAVAPPGVAALSIHSAVAQLPGQPVYPAAFPQMAPTDVPPSPHHTVQNMRATPPQPALPPQPTLPPQPVLPPQPTLPPQPVLPPQPTRPPQPVLPPQPMLPPQPVLPPQPALPVRPEPLQPHLPEQAAPAATPGSQILLGHPAPYAVDVAAQVPTVPVPPAAVLSPPLPEVLLPAAPELLPQFPSSLATVSASVQSVPTQTATLLPPANPPLPGGPGIASPCPTVQLTVEPVQEEQASQDKPPGLPQSCESYGGSDVTSGKELSDSCEGAFGGGRLEGRAARKHHRRSTRARSRQERASRPRLTILNVCNTGDKMVECQLETHNHKMVTFKFDLDGDAPDEIATYMVEHDFILQAERETFIEQMKDVMDKAEDMLSEDTDADRGSDPGTSPPHLSTCGLGTGEESRQSQANAPVYQQNVLHTGKRWFIICPVAEHPAPEAPESSPPLPLSSLPPEASQGPCRGLTLPCLPWRRAACGAVFLSLFSAESAQSKQPPDSAPYKDQLSSKEQPSFLASQQLLSQAGPSNPPGAPPAPLAPSSPPVTALPQDGAAPATSTMPEPASGTASQAGGPGTPQGLTSELETSQPLAETHEAPLAVQPLVVGLAPCTPAPEAASTRDASAPREPLPPPAPEPSPHSGTPQPALGQPAPLLPAAVGAVSLATSQLPSPPLGPTVPPQPPSALESDGEGPPPRVGFVDSTIKSLDEKLRTLLYQEHVPTSSASAGTPVEVGDRDFTLEPLRGDQPRSEVCGGDLALPPVPKEAVSGRVQLPQPLVEKSELAPTRGAVMEQGTSSSMTAESSPRSMLGYDRDGRQVASDSHVVPSVPQDVPAFVRPARVEPTDRDGGEAGESSAEPPPSDMGTVGGQASHPQTLGARALGSPRKRPEQQDVSSPAKTVGRFSVVSTQDEWTLASPHSLRYSAPPDVYLDEAPSSPDVKLAVRRAQTASSIEVGVGEPVSSDSGDEGPRARPPVQKQASLPVSGSVAGDFVKKATAFLQRPSRAGSLGPETPSRVGMKVPTISVTSFHSQSSYISSDNDSELEDADIKKELQSLREKHLKEISELQSQQKQEIEALYRRLGKPLPPNVGFFHTAPPTGRRRKTSKSKLKAGKLLNPLVRQLKVVASSTGHLADSSRGPPAKDPAQASVGLTADSTGLSGKAVQTQQPCSVRASLSSDICSGLASDGGGARGQGWTVYHPTSERVTYKSSSKPRARFLSGPVSVSIWSALKRLCLGKEHSSRSSTSSLAPGPEPGPQPALHVQAQVNNSNNKKGTFTDDLHKLVDEWTSKTVGAAQLKPTLNQLKQTQKLQDMEAQAGWAAPGEARAMTAPRAGVGMPRLPPAPGPLSTTVIPGAAPTLSVPTPDGALGTARRNQVWFGLRVPPTACCGHSTQPRGGQRVGSKTASFAASDPVRS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
13PhosphorylationGRRDVPGTLMEPGRG
CCCCCCCCCCCCCCC
19.50-
19MethylationGTLMEPGRGAGPAGM
CCCCCCCCCCCCCCC
42.3716226709
30MethylationPAGMAEPRAKAARPG
CCCCCCHHHHHCCCC
39.98-
45PhosphorylationPQRFLRRSVVESDQE
HHHHHHHHHHCCCCC
24.8721955146
49PhosphorylationLRRSVVESDQEEPPG
HHHHHHCCCCCCCCC
32.7430175587
210PhosphorylationRGSFKTVYKGLDTET
CCCEEEEECCCCHHH
12.45-
232PhosphorylationELQDRKLTKLERQRF
HHHHHCCHHHHHHHH
36.30-
275PhosphorylationKRCIVLVTELMTSGT
CCEEEEEEECCCCCH
21.1730387612
280PhosphorylationLVTELMTSGTLKTYL
EEEECCCCCHHHHHH
18.8024719451
282PhosphorylationTELMTSGTLKTYLKR
EECCCCCHHHHHHHH
25.5024719451
286PhosphorylationTSGTLKTYLKRFKVM
CCCHHHHHHHHHCCC
14.5130387612
300PhosphorylationMKPKVLRSWCRQILK
CCHHHHHHHHHHHHH
26.7722964224
347PhosphorylationIGDLGLATLKRASFA
ECHHHHHHHHHHHHH
37.5421406692
349UbiquitinationDLGLATLKRASFAKS
HHHHHHHHHHHHHHH
41.38-
352PhosphorylationLATLKRASFAKSVIG
HHHHHHHHHHHHHHC
29.7517081983
356PhosphorylationKRASFAKSVIGTPEF
HHHHHHHHHHCCCCH
18.6125850435
391PhosphorylationMCMLEMATSEYPYSE
HHHHHHHHCCCCHHH
22.3026552605
392PhosphorylationCMLEMATSEYPYSEC
HHHHHHHCCCCHHHH
26.1226552605
394PhosphorylationLEMATSEYPYSECQN
HHHHHCCCCHHHHCC
13.7726552605
396PhosphorylationMATSEYPYSECQNAA
HHHCCCCHHHHCCHH
19.0526552605
397PhosphorylationATSEYPYSECQNAAQ
HHCCCCHHHHCCHHH
27.6526552605
406PhosphorylationCQNAAQIYRKVTCGI
HCCHHHHHHHHCCCC
7.7226552605
442PhosphorylationCKNKEERYEIKDLLS
HCCHHHHHHHHHHHH
25.8622817900
473PhosphorylationEDHGRKSTIALRLWV
CCCCCCCEEEEEEEE
17.1924719451
560PhosphorylationKEQQDVGSPDKARGP
HHHCCCCCCCCCCCC
29.7625159151
1150PhosphorylationVTSGKELSDSCEGAF
CCCCCHHHHCCCCCC
28.6819664994
1152PhosphorylationSGKELSDSCEGAFGG
CCCHHHHCCCCCCCC
15.6428985074
1175PhosphorylationRKHHRRSTRARSRQE
HHHHHHHHHHHHHHH
26.91-
1262PhosphorylationDKAEDMLSEDTDADR
HHHHHHHCCCCCCCC
27.1326471730
1265PhosphorylationEDMLSEDTDADRGSD
HHHHCCCCCCCCCCC
29.0927251275
1271PhosphorylationDTDADRGSDPGTSPP
CCCCCCCCCCCCCCC
41.3428348404
1275PhosphorylationDRGSDPGTSPPHLST
CCCCCCCCCCCCCCC
43.3728985074
1276PhosphorylationRGSDPGTSPPHLSTC
CCCCCCCCCCCCCCC
42.2024076635
1281PhosphorylationGTSPPHLSTCGLGTG
CCCCCCCCCCCCCCC
20.7223312004
1282PhosphorylationTSPPHLSTCGLGTGE
CCCCCCCCCCCCCCH
19.5623312004
1287PhosphorylationLSTCGLGTGEESRQS
CCCCCCCCCHHHHHH
46.6023312004
1329 (in isoform 2)Phosphorylation-47.2728348404
1330 (in isoform 2)Phosphorylation-28.9528348404
1588PhosphorylationFVDSTIKSLDEKLRT
CCHHHHHHHHHHHHH
36.8823312004
1595PhosphorylationSLDEKLRTLLYQEHV
HHHHHHHHHHHHHCC
31.3929978859
1598PhosphorylationEKLRTLLYQEHVPTS
HHHHHHHHHHCCCCC
18.2429978859
1604O-linked_GlycosylationLYQEHVPTSSASAGT
HHHHCCCCCCCCCCC
33.9432574038
1604PhosphorylationLYQEHVPTSSASAGT
HHHHCCCCCCCCCCC
33.9429978859
1605PhosphorylationYQEHVPTSSASAGTP
HHHCCCCCCCCCCCC
20.1729978859
1606PhosphorylationQEHVPTSSASAGTPV
HHCCCCCCCCCCCCE
28.8128348404
1608PhosphorylationHVPTSSASAGTPVEV
CCCCCCCCCCCCEEE
29.2228348404
1611PhosphorylationTSSASAGTPVEVGDR
CCCCCCCCCEEECCC
24.7128348404
1631DimethylationPLRGDQPRSEVCGGD
CCCCCCCCHHCCCCC
39.55-
1631MethylationPLRGDQPRSEVCGGD
CCCCCCCCHHCCCCC
39.5552720005
1677PhosphorylationGAVMEQGTSSSMTAE
CCHHCCCCCCCCCCC
25.7329978859
1678PhosphorylationAVMEQGTSSSMTAES
CHHCCCCCCCCCCCC
27.5224719451
1679PhosphorylationVMEQGTSSSMTAESS
HHCCCCCCCCCCCCC
24.7829978859
1680PhosphorylationMEQGTSSSMTAESSP
HCCCCCCCCCCCCCC
21.6629978859
1682PhosphorylationQGTSSSMTAESSPRS
CCCCCCCCCCCCCCH
29.2629978859
1685PhosphorylationSSSMTAESSPRSMLG
CCCCCCCCCCCHHCC
43.0827251275
1686PhosphorylationSSMTAESSPRSMLGY
CCCCCCCCCCHHCCC
18.8121815630
1689PhosphorylationTAESSPRSMLGYDRD
CCCCCCCHHCCCCCC
23.03-
1693PhosphorylationSPRSMLGYDRDGRQV
CCCHHCCCCCCCCEE
12.12-
1736PhosphorylationDGGEAGESSAEPPPS
CCCCCCCCCCCCCCC
33.6521733846
1765PhosphorylationLGARALGSPRKRPEQ
HCHHHCCCCCCCHHH
23.5223909892
1776PhosphorylationRPEQQDVSSPAKTVG
CHHHCCCCCCCEEEE
38.6023312004
1777PhosphorylationPEQQDVSSPAKTVGR
HHHCCCCCCCEEEEE
28.8229496963
1798PhosphorylationQDEWTLASPHSLRYS
CCCEEECCCCCCCCC
26.6825159151
1801PhosphorylationWTLASPHSLRYSAPP
EEECCCCCCCCCCCC
20.2327251275
1804PhosphorylationASPHSLRYSAPPDVY
CCCCCCCCCCCCCEE
17.9326657352
1805PhosphorylationSPHSLRYSAPPDVYL
CCCCCCCCCCCCEEC
28.0627732954
1811PhosphorylationYSAPPDVYLDEAPSS
CCCCCCEECCCCCCC
18.8030175587
1817PhosphorylationVYLDEAPSSPDVKLA
EECCCCCCCCCHHHH
62.6425159151
1818PhosphorylationYLDEAPSSPDVKLAV
ECCCCCCCCCHHHHH
24.8625159151
1830PhosphorylationLAVRRAQTASSIEVG
HHHHHHHCCCCEEEE
27.7622468782
1832PhosphorylationVRRAQTASSIEVGVG
HHHHHCCCCEEEECC
34.9222468782
1843PhosphorylationVGVGEPVSSDSGDEG
EECCCCCCCCCCCCC
38.8627732954
1844PhosphorylationGVGEPVSSDSGDEGP
ECCCCCCCCCCCCCC
35.7127732954
1846PhosphorylationGEPVSSDSGDEGPRA
CCCCCCCCCCCCCCC
50.5227732954
1862PhosphorylationPPVQKQASLPVSGSV
CCCCCCCCCCCCCCH
30.6130266825
1866PhosphorylationKQASLPVSGSVAGDF
CCCCCCCCCCHHHHH
24.3430266825
1868PhosphorylationASLPVSGSVAGDFVK
CCCCCCCCHHHHHHH
10.9930266825
1885PhosphorylationTAFLQRPSRAGSLGP
HHHHHCCCCCCCCCC
36.6328555341
1889PhosphorylationQRPSRAGSLGPETPS
HCCCCCCCCCCCCCC
29.2125159151
1894PhosphorylationAGSLGPETPSRVGMK
CCCCCCCCCCCCCCC
29.6921815630
1896PhosphorylationSLGPETPSRVGMKVP
CCCCCCCCCCCCCCC
47.2020068231
1906PhosphorylationGMKVPTISVTSFHSQ
CCCCCEEEEEEECCC
23.0930177828
1908PhosphorylationKVPTISVTSFHSQSS
CCCEEEEEEECCCCC
20.9130177828
1909PhosphorylationVPTISVTSFHSQSSY
CCEEEEEEECCCCCC
20.8530177828
1912PhosphorylationISVTSFHSQSSYISS
EEEEEECCCCCCCCC
29.7330177828
1914PhosphorylationVTSFHSQSSYISSDN
EEEECCCCCCCCCCC
28.2930177828
1915PhosphorylationTSFHSQSSYISSDND
EEECCCCCCCCCCCC
20.8830177828
1916PhosphorylationSFHSQSSYISSDNDS
EECCCCCCCCCCCCH
15.2930177828
1918PhosphorylationHSQSSYISSDNDSEL
CCCCCCCCCCCCHHH
24.3330177828
1919PhosphorylationSQSSYISSDNDSELE
CCCCCCCCCCCHHHC
30.7630177828
1923PhosphorylationYISSDNDSELEDADI
CCCCCCCHHHCHHHH
50.7830177828
1936PhosphorylationDIKKELQSLREKHLK
HHHHHHHHHHHHHHH
41.8621406692
2009PhosphorylationRQLKVVASSTGHLAD
HHHHHHHHCCCCCCC
19.4727732954
2010PhosphorylationQLKVVASSTGHLADS
HHHHHHHCCCCCCCC
28.7727732954
2011PhosphorylationLKVVASSTGHLADSS
HHHHHHCCCCCCCCC
26.5627732954
2056O-linked_GlycosylationQPCSVRASLSSDICS
CCCCCEEECCCCHHH
20.4432574038
2056PhosphorylationQPCSVRASLSSDICS
CCCCCEEECCCCHHH
20.44-
2063PhosphorylationSLSSDICSGLASDGG
ECCCCHHHCCCCCCC
36.8629116813
2067PhosphorylationDICSGLASDGGGARG
CHHHCCCCCCCCCCC
41.6611280764
2078PhosphorylationGARGQGWTVYHPTSE
CCCCCCCEEECCCCC
20.29-
2091PhosphorylationSERVTYKSSSKPRAR
CCCEEECCCCCCCHH
29.4527251275
2101PhosphorylationKPRARFLSGPVSVSI
CCCHHHCCCCCHHHH
38.0424719451
2110PhosphorylationPVSVSIWSALKRLCL
CCHHHHHHHHHHHHC
23.2727251275
2128PhosphorylationHSSRSSTSSLAPGPE
CCCCCCCCCCCCCCC
25.88-
2129PhosphorylationSSRSSTSSLAPGPEP
CCCCCCCCCCCCCCC
28.74-
2155UbiquitinationVNNSNNKKGTFTDDL
ECCCCCCCEECCHHH
66.36-
2157PhosphorylationNSNNKKGTFTDDLHK
CCCCCCEECCHHHHH
32.0425159151
2159PhosphorylationNNKKGTFTDDLHKLV
CCCCEECCHHHHHHH
28.5728450419
2170PhosphorylationHKLVDEWTSKTVGAA
HHHHHHHHHCCCCHH
20.4922210691
2171PhosphorylationKLVDEWTSKTVGAAQ
HHHHHHHHCCCCHHH
27.6622210691
2173PhosphorylationVDEWTSKTVGAAQLK
HHHHHHCCCCHHHHH
24.76-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of WNK2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of WNK2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of WNK2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SGK1_HUMANSGK1physical
20525693

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of WNK2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"WNK2 is a novel regulator of essential neuronal cation-chloridecotransporters.";
Rinehart J., Vazquez N., Kahle K.T., Hodson C.A., Ring A.M.,Gulcicek E.E., Louvi A., Bobadilla N.A., Gamba G., Lifton R.P.;
J. Biol. Chem. 286:30171-30180(2011).
Cited for: FUNCTION, TISSUE SPECIFICITY, AND PHOSPHORYLATION AT SER-45; SER-560;SER-1150; SER-1262; SER-1588; SER-1685; SER-1736; SER-1817; SER-1818;SER-1862 AND SER-2067.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49; SER-1817; SER-1818;SER-1862 AND SER-1889, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, ANDMASS SPECTROMETRY.

TOP